News

07 DECEMBER, 2017

Bluebee adds NEN 7510:2011 Certification to its Security Portfolio

The security of Bluebee’s customer data is a priority highlighted by the recent NEN 7510:2011 certification, and demonstrates the company’s continued strive for security compliance and excellence in handling healthcare data. The NEN 7510:2011 standard is the Dutch standard detailing requirements on information security for organizations processing and managing patient data. Required by the Ministry… Learn More

10 NOVEMBER, 2017

Lexogen and Bluebee Partner to Bring the SLAMseq Metabolic RNA Sequencing Data Analysis Pipeline to the Users

RIJSWIJK, The Netherlands and Vienna, Austria — November 10, 2017 — Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk pipeline on Bluebee’s private cloud-based platform, making it available to analyze data generated by every user of the SLAMseq Metabolic… Learn More

06 NOVEMBER, 2017

Overcoming High Sequence Complexity with the PacBio De Novo Assembly Pipeline, on the Bluebee Platform

Complex elements – repetitive regions, copy number variants, or structural variations – are challenging, if not impossible to sequence using short-read technologies. PacBio’s long-read technology based on Single Molecule, Real-Time (SMRT) sequencing, delivers long reads with uniform coverage, allowing comprehensive de novo genome assemblies that can overcome the short-read sequencing challenges of complex DNA regions…. Learn More

03 NOVEMBER, 2017

ASHG 2017 was all About Expediting the Analysis and Interpretation of Research and Clinical Data

The theme of this year’s annual gathering of geneticists at the American Society of Human Genetics conference held in Orlando was centered around expediting the analysis and interpretation of both research and clinical data. The conference kicked off with a talk by ASHG President Dr. Nancy Cox, highlighting the need for diversity in genetic studies to… Learn More

Sign up for our newsletter

Our latest news, publications and developments delivered to your inbox